Investigational Drug Information for Enobosarm
✉ Email this page to a colleague
What is the development status for investigational drug Enobosarm?
Enobosarm is an investigational drug.
There have been 11 clinical trials for Enobosarm.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Urinary Incontinence, Enuresis, and Breast Neoplasms. The leading clinical trial sponsors are GTx, Veru Inc., and Martin Performance.
Summary for Enobosarm
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 171 |
| WIPO Patent Applications | 61 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 3 (2011-07-01) |
| Vendors | 53 |
Recent Clinical Trials for Enobosarm
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer | Veru Inc. | Phase 2 |
| Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer | Veru Inc. | Phase 3 |
| Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence | GTx | Phase 2 |
Clinical Trial Summary for Enobosarm
Top disease conditions for Enobosarm
Top clinical trial sponsors for Enobosarm
US Patents for Enobosarm
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
